Transformative Leader Award
The Transformative Leader Award recognizes HIVMA members who have transformed the field with demonstrated significant achievement in HIV clinical care, provider education, research or advocacy. Significant achievement will be based on overall achievement and contributions that transcend a single institution and that have impacted patient care within a city, region, state or nationally.
2024 HIVMA Transformative Leader Award Winner
Daniel R. Kuritzkes, MD, FIDSA
Dr. Kuritzkes, Harriet Ryan Albee Professor of Medicine at Harvard Medical School, is a trailblazer in advancing knowledge of drug-resistant HIV who has had a transformative impact on the understanding and care of people with HIV and on countless trainees and colleagues.
He is a leading expert in drug-resistant HIV worldwide. Among his most significant contributions are his work to establish the significance of resistant mutations against nucleoside reverse transcriptase inhibitors and his insight that certain drug-resistance mutations reduce viral fitness. Each of these research developments has proven fundamental to the field’s understanding of resistance to HIV medications and advanced clinical care, with drug-resistance testing becoming a standard of HIV care.
Additionally, Dr. Kuritzkes is chair of the World Health Organization’s HIV Resistance Network Steering Group. He previously led the Advancing Clinical Therapeutics Globally group, where he conducted clinical trials that resulted in lifesaving advances in HIV management. Included in his over 300-article repertoire are reports that have been published in The New England Journal of Medicine, JAMA, Annals of Internal Medicine and other high-impact journals.
Past Awardees
2023 – Judith Feinberg, MD, FACP, FIDSA